Key Summary: On March 30, 2023, NexPoint Real Estate Opportunities (11.7%) discussed with management the pursuit of strategic alternatives and sought a board seat. On June 27, 2023, NexPoint (12%) announced its intention to withhold votes against all three Board members at the AGM, criticizing the Board's oversight and planning to scrutinize the proposed acquisition by Gurnet Point Capital, LLC, and Novo Nordisk Foundation, potentially opposing it if the purchase price isn't justified.Market Cap: $125 million | Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company.
On March 30, 2023, NexPoint Real Estate Opportunities (11.7%) stated that it discussed with management that the Company should pursue strategic alternatives and have sought a seat on the board of directors. Source
On June 27, 2023, NexPoint Real Estate Opportunities (12%) issued a press release and open letter expressing its intention to withhold votes against all three Board members at the upcoming AGM. It criticizes the Board's lack of oversight and plan to scrutinize the Proposed Acquisition of the company by Gurnet Point Capital, LLC and Novo Nordisk Foundation, potentially voting against it if it doesn't justify the proposed purchase price.
Comments